## NotesToFinancialStatementsStockholdersEquityAndStockBasedCompensationDisclosureTextBlockTables

**Year Ended**

|  | Sep 25, 2010 |
| --- | --- |
| **      Components of Accumulated Other Comprehensive Income, Net of Taxes** | The following
table summarizes the components of AOCI, net of taxes, as of the
three years ended September 25, 2010 (in millions):

                                              2010                2009          
2008           
 ───────────────────────────────────────────────────────────────────────────────
────────────────────
  Net unrealized gains/losses                 $          171      $         48  
$         (70  
  Net unrecognized                                      (252                 1  
19  
  Cumulative foreign currency                             35                28  
42  
  Accumulated other                           $          (46      $         77  
$          (9
 |
| **      Other Comprehensive Income Related to Derivatives** | The following
table summarizes activity in other comprehensive income related to
derivatives, net of taxes, held by the Company during the three
years ended September 25, 2010 (in millions):

                                                        2010                2009
2008          
 ───────────────────────────────────────────────────────────────────────────────
───────────────────────────────
  Changes in fair value of                              $         (180      $   
204      $          7  
  Adjustment for net                                               (73          
(222                12  
  Change in unrecognized                                $         (253      $   
(18      $         19
 |
| **      Restricted Stock Activity** | A summary of
the Company’s RSU activity and related information for the
three years ended September 25, 2010, is as follows (in
thousands, except per share amounts):

                                          Weighted-  
                                            Average  
                                              Grant  
                                               Date  
                                               Fair  
                                              Value  
 ─────────────────────────────────────────────────────
  Balance at                   4,675         $52.98  
  Restricted stock units       4,917        $162.61  
  Restricted stock units      (2,195         $25.63  
  Restricted stock units        (357        $119.12  
  Balance at                   7,040        $134.91  
  Restricted stock units       7,786        $111.80  
  Restricted stock units      (1,935        $124.87  
  Restricted stock units        (628        $121.28  
  Balance at                  12,263        $122.52  
  Restricted stock units       6,178        $214.37  
  Restricted stock units      (4,685        $119.85  
  Restricted stock units        (722        $147.56  
  Balance at                  13,034        $165.63
 |
| **      Stock Option and RSU Activity and Related Information** | A summary of
the Company’s stock option and RSU activity and related
information for the three years ended September 25, 2010, is
as follows (in thousands, except per share amounts and contractual
term in years):

                                           Outstanding                          
                                                Number      Weighted-           
  Balance at                   67,827           49,751         $43.91           
  Restricted stock units       (9,834                0             $0           
  Options granted              (9,359            9,359        $171.36           
  Options                       1,236           (1,236         $98.40           
  Restricted stock units          714                0             $0           
  Options                           0          (13,728         $27.88           
  Plan shares                     (12                0             $0           
  Balance at                   50,572           44,146         $74.39           
  Restricted stock units      (15,572                0             $0           
  Options granted                (234              234        $106.84           
  Options                       1,241           (1,241        $122.98           
  Restricted stock units        1,256                0             $0           
  Options                           0           (8,764         $41.78           
  Plan shares                      (2                0             $0           
  Balance at                   37,261           34,375         $81.17           
  Additional shares            36,000                0             $0           
  Restricted stock units      (12,356                0             $0           
  Options granted                 (34               34        $202.00           
  Options assumed                   0               98         $11.99           
  Options                         430             (430        $136.27           
  Restricted stock units        1,444                0             $0           
  Options                           0          (12,352         $62.69           
  Plan shares                      (8                0             $0           
  Balance at                   62,737           21,725         $90.46      2.85 
4,385,291  
  Exercisable at                                17,791         $77.74      2.57 
3,817,663  
  Expected to vest after                         3,880        $148.03      4.12 
559,882
 |
| **      Weighted-Average Assumptions and Resulting Estimates of Weighted-Average Fair Value Per Share of Stock Options Granted and Stock Purchase Rights** | The
weighted-average assumptions used for stock options granted do not
apply to employee stock options assumed in conjunction with
business acquisitions during the year ended September 25,
2010. The weighted-average fair value of stock options assumed
during the year ended September 25, 2010 was $216.82. There
were no stock options assumed during 2009 and 2008. The
weighted-average assumptions used for the three years ended
September 25, 2010, and the resulting estimates of
weighted-average fair value per share of options granted and of
stock purchase rights during those periods are as
follows:

                                                     2010                    
2009                      2008                  
  Expected life of stock                                       10 years         
4.54 years                3.41 years  
  options                                                                       
  Expected life of stock                                       6 months         
6 months                  6 months  
  purchase rights                                                               
 ───────────────────────────────────────────────────────────────────────────────
──────────────────────────────────────────────
  Interest rate - stock                                           3.71%         
2.04%                     3.40%  
  Interest rate - stock                                           0.25%         
0.58%                     3.48%  
  Volatility - stock                                             36.30%         
50.98%                    45.64%  
  Volatility - stock purchase                                    33.28%         
52.16%                    38.51%  
  Dividend yields                                                     0         
0                         0  
  Weighted-average fair value                        $           108.58      $  
46.71      $              62.73  
  Weighted-average fair value                        $            45.03      $  
30.62      $              42.27
 |
| **      Summary of the Stock-Based Compensation Expense** | The following
table provides a summary of the stock-based compensation expense
included in the Consolidated Statements of Operations for the three
years ended September 25, 2010 (in millions):

                            2010               2009               2008          
 ───────────────────────────────────────────────────────────────────────────────
──
  Cost of sales             $         151      $         114      $          80 
  Research and                        323                258                185 
  Selling, general and                405                338                251 
  Total stock-based         $         879      $         710      $         516
 |